Aethlon Medical, Inc. (AEMD)
| Market Cap | 53.08M |
| Revenue (ttm) | 791,070 |
| Net Income (ttm) | -8.57M |
| Shares Out | 12.83M |
| EPS (ttm) | -0.67 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 147,601 |
| Open | 3.47 |
| Previous Close | 3.50 |
| Day's Range | 3.42 - 3.58 |
| 52-Week Range | 1.29 - 12.49 |
| Beta | 0.60 |
| Analysts | Buy |
| Price Target | 9.33 (+170.4%) |
| Est. Earnings Date | Oct 28, 2021 |
About AEMD
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pitts...
Financial Performance
In 2020, AEMD's revenue was $659,104, an increase of 1.37% compared to the previous year's $650,187. Losses were -$7.89 million, 23.7% more than in 2019.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for AEMD stock is "Buy" and the 12-month stock price forecast is 9.33.
News
Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
SAN DIEGO, Sept. 7, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, toda...
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 9, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today...
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021
SAN DIEGO, July 29, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial r...
This Is Why Stocks Are Down Today
Stocks begin week with the market selling off; why? The post This Is Why Stocks Are Down Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update
SAN DIEGO, June 24, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, toda...
Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021
SAN DIEGO, June 21, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial r...
Why Aethlon Medical's Stock Is Plunging Today
After surging 400% yesterday, Aethlon Medical, Inc. (NASDAQ: AEMD) shares are trading lower after the company announced a 1.38-million share registered direct offering priced at $9 per share. The gross ...
Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
SAN DIEGO, June 10, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq:AEMD), a medical device technology company focused on unmet needs in global health, today announced that it has entered into a defi...
AEMD Stock: The Historic Covid-19 News Sending Aethlon Medical Rocketing 350%+
Shares of AEMD stock are taking off on Wednesday following the firm's June 3 report of its coronavirus treatment returning promising results. The post AEMD Stock: The Historic Covid-19 News Sending Aeth...
Why Aethlon Medical Stock Skyrocketing?
Aethlon Medical Inc (NASDAQ: AEMD) stock surged probably in reaction to Zacks Article 'AEMD: First Ever In Vivo Removal Of COVID Virus From Bloodstream Of An Infected Patient.' The company recently anno...
Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®
SAN DIEGO, June 3, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced the publication of a pre-print ...
Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences
SAN DIEGO, March 1, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that the company will particip...
Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021
SAN DIEGO, Feb. 4, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial re...
Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
SAN DIEGO, Jan. 6, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, tod...
Aethlon Medical to Present at the H.C. Wainwright BioConnect 2021 Conference
SAN DIEGO, Jan. 4, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, tod...
Aethlon Medical News Alert: Why AEMD Stock Is Rocketing Higher Today
Aethlon Medical (AEMD) news for Wednesday concerning the progress in an EFS for one of its medical devices has AEMD stock soaring higher. The post Aethlon Medical News Alert: Why AEMD Stock Is Rocketing...
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D.
SAN DIEGO, Nov. 3, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, annou...
Aethlon Medical, Inc. (AEMD) CEO Tim Rodell on Q2 2021 Results - Earnings Call Transcript
Aethlon Medical, Inc. (AEMD) CEO Tim Rodell on Q2 2021 Results - Earnings Call Transcript
Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update
SAN DIEGO, Oct. 28, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on developing products to diagnose and treat life and organ threatening disease...
Aethlon Medical To Release Second Quarter Financial Results and Host Conference Call on October 28, 2020
SAN DIEGO, Oct. 19, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in global health, today announced that it will issue financial r...
Aethlon Medical to Present at the LD Micro 500 Virtual Conference
SAN DIEGO, Aug. 27, 2020 /PRNewswire/ -- Aethlon Medical, Inc.
Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q1 2021 Results - Earnings Call Transcript
Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q1 2021 Results - Earnings Call Transcript
Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update
SAN DIEGO, Aug. 11, 2020 /PRNewswire/ -- Aethlon Medical, Inc.
Aethlon Medical To Release First Quarter Financial Results and Host Conference Call on August 11, 2020
SAN DIEGO, Aug. 4, 2020 /PRNewswire/ -- Aethlon Medical, Inc.
Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q4 2020 Results - Earnings Call Transcript
Aethlon Medical, Inc. (AEMD) CEO Timothy Rodell on Q4 2020 Results - Earnings Call Transcript